These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25791284)

  • 1. Model of complex chiral drug metabolic systems and numerical simulation of the remaining chirality toward analysis of dynamical pharmacological activity.
    Ogino Y; Asahi T
    J Theor Biol; 2015 May; 373():117-31. PubMed ID: 25791284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS/MS and chiroptical spectroscopic analyses of multidimensional metabolic systems of chiral thalidomide and its derivatives.
    Ogino Y; Tanaka M; Shimozawa T; Asahi T
    Chirality; 2017 Jun; 29(6):282-293. PubMed ID: 28422447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically active compounds in the environment and their chirality.
    Kasprzyk-Hordern B
    Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselectivity in drug metabolism.
    Lu H
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chirality and pharmacokinetics: an area of neglected dimensionality?
    Hutt AJ
    Drug Metabol Drug Interact; 2007; 22(2-3):79-112. PubMed ID: 17708062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chirality and drugs].
    Testa B; Reist M; Carrupt PA
    Ann Pharm Fr; 2000 Jul; 58(4):239-46. PubMed ID: 10915971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral inversion of drugs: coincidence or principle?
    Wsól V; Skálová L; Szotáková B
    Curr Drug Metab; 2004 Dec; 5(6):517-33. PubMed ID: 15578945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites.
    Reist M; Carrupt PA; Francotte E; Testa B
    Chem Res Toxicol; 1998 Dec; 11(12):1521-8. PubMed ID: 9860497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
    Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.
    Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
    Chirality; 1995; 7(1):44-52. PubMed ID: 7702998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.
    Fortuna A; Alves G; Falcão A
    Biomed Chromatogr; 2014 Jan; 28(1):27-58. PubMed ID: 23946142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Input rate-dependent stereoselective pharmacokinetics: effect of pulsatile oral input.
    Mehvar R
    Chirality; 1994; 6(3):185-95. PubMed ID: 8024949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of drug, narcotic and psychotropic drug chirality by statistical methods].
    Noszál B; Schiller Z
    Acta Pharm Hung; 1999 Apr; 69(2):85-90. PubMed ID: 10389303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods.
    Coelho MM; Fernandes C; Remião F; Tiritan ME
    Molecules; 2021 May; 26(11):. PubMed ID: 34070985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels.
    Yin N; Pei J; Lai L
    Mol Biosyst; 2013 Jun; 9(6):1381-9. PubMed ID: 23478789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiomers of thalidomide: blood distribution and the influence of serum albumin on chiral inversion and hydrolysis.
    Eriksson T; Björkman S; Roth B; Fyge A; Höglund P
    Chirality; 1998; 10(3):223-8. PubMed ID: 9499573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incoming guidelines on chirality. A challenge for pharmacokinetics in drug development.
    Marzo A
    Arzneimittelforschung; 1994 Jun; 44(6):791-3. PubMed ID: 8053982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral discrimination between thalidomide enantiomers using a solid surface with two-dimensional chirality.
    Nakanishi T; Yamakawa N; Asahi T; Shibata N; Ohtani B; Osaka T
    Chirality; 2004; 16 Suppl():S36-9. PubMed ID: 15239071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.